DCF — MEMORIALCARE SADDLEBACK MED CTR
Enterprise Value: $-826.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-826.5M
Enterprise Value
$-256.9M
PV of Cash Flows
$-569.6M
PV of Terminal Value
$-917.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $380.6M | $-54.0M | -14.0% | $-70.1M | $-63.7M |
| Year 2 | $392.0M | $-51.7M | -13.0% | $-68.3M | $-56.4M |
| Year 3 | $403.8M | $-49.2M | -12.0% | $-66.3M | $-49.8M |
| Year 4 | $415.9M | $-48.6M | -12.0% | $-66.2M | $-45.2M |
| Year 5 | $428.4M | $-49.0M | -11.0% | $-67.1M | $-41.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-826.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$369.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.14687693738042232
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5